Therapeutic Drug Monotoring: CYP2C19 genetic polymorphism and major depression

被引：0
|
作者：
Adamovic, I [1 ]
Michaelis, S. [1 ]
Streit, F. [1 ]
Binder, L. [1 ]
Degner, D. [1 ]
机构：
[1] Univ Gottingen, Gottingen, Germany
来源：
PHARMACOPSYCHIATRY | 2020年 / 53卷 / 02期
关键词：
D O I：
10.1055/s-0039-3403049
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P7.4
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [41] Prevalence of CYP2C19 polymorphism in a Mexican population
    Gonzalez, EG
    Gonzalez, EG
    Maldonado-Garza, HJJ
    Padilla, FJB
    GASTROENTEROLOGY, 2004, 126 (04) : A316 - A316
  • [42] CYP2C19*3 polymorphism in patients with endometriosis
    Bento, I. A.
    Silva, K. S. F. e
    Moura, K. K. V. O.
    Ribeiro Junior, C. L.
    da Costa, I. R.
    GENETICS AND MOLECULAR RESEARCH, 2019, 18 (02)
  • [43] CYP2C19 polymorphism and risk for essential tremor
    Alonso-Navarro, H.
    Martinez, C.
    Garcia-Martin, E.
    Benito-Leon, J.
    Garcia-Ferrer, I.
    Vazquez-Torres, P.
    Puertas, I.
    Lopez-Alburquerqe, T.
    Agundez, J. A. G.
    Jimenez-Jimenez, F. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 73 - 73
  • [44] CYP2C19 polymorphism increases the risk of endometriosis
    Denise Maria Christofolini
    Aline Amaro
    Fernanda Mafra
    Amanda Sonnewend
    Bianca Bianco
    Caio Parente Barbosa
    Journal of Assisted Reproduction and Genetics, 2015, 32 : 91 - 94
  • [45] Frequency of CYP2C19 Polymorphism in Ischemic Patients
    Shawky, A.
    PUBLIC HEALTH GENOMICS, 2018, 21 : 15 - 15
  • [46] CYP2C19 polymorphism and risk for essential tremor
    Alonso-Navarro, Hortensia
    Martinez, Carmen
    Garcia-Martin, Elena
    Benito-Leon, Julian
    Garcia-Ferrer, Isabel
    Vazquez-Torres, Pilar
    Puertas, Inmaculade
    Lopez-Alburquerque, Tomas
    Agundez, Jose A. G.
    Jimenez-Jimenez, Felix Javier
    EUROPEAN NEUROLOGY, 2006, 56 (02) : 119 - 123
  • [47] Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
    Kim, K. -A.
    Song, W. -K.
    Kim, K. -R.
    Park, J. -Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 697 - 703
  • [48] Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder
    Zastrozhin, M. S.
    Skryabin, V. Yu
    Petukhov, A. E.
    Torrado, M. V.
    Pankratenko, E. P.
    Zastrozhina, A. K.
    Grishina, E. A.
    Ryzhikova, K. A.
    Shipitsyn, V. V.
    Bryun, E. A.
    Sychev, D. A.
    PHARMACOGENOMICS JOURNAL, 2021, 21 (04): : 435 - 439
  • [49] Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder
    M. S. Zastrozhin
    V. Yu Skryabin
    A. E. Petukhov
    M. V. Torrado
    E. P. Pankratenko
    A. K. Zastrozhina
    E. A. Grishina
    K. A. Ryzhikova
    V. V. Shipitsyn
    E. A. Bryun
    D. A. Sychev
    The Pharmacogenomics Journal, 2021, 21 : 435 - 439
  • [50] CYP2C19 GENETIC POLYMORPHISM ON CLOPIDOGREL RESPONSE IN VIETNAMESE PATIENTS WITH CORONARY STENTING
    Kim, N. T.
    Nguyen, M. N. T.
    Do, D. L.
    Nguyen, Q. H.
    Nguyen, T. T. T.
    Truong, T. H.
    ATHEROSCLEROSIS, 2020, 315 : E83 - E84
12345